Accelerated Idioventricular Rhythm In a Young Normal Male
- Clinical Use of Sustained-Release Procainamide in Treatment of Cardiac Arrhythmias. Michelson, Eric L.; McGeehin III, Frank C.; Levin, Barry K. // Angiology;Jul1988 Part 2, Vol. 39 Issue 7, p647
Although procainamide has been available, and used, in the treatment of atrial and ventricular arrhythmias for approximately thirty years, its short half-life has made it less than optimal for long-term arrhythmia management in ambulatory patients. Currently available sustained-release...
- arrhythmias. // Royal Society of Medicine: Medicines;2002, p87
The article presents information on arrhythmias or abnormalities of heart rhythm or rate of heartbeat. These diseases are usually caused by disturbances of the electrical impulses and their conduction within the heart. Treatment of each type of disorder is usually under specialist supervision...
- Bradycardia Induced by Hyperkalemia. Vuckovic, Karen; Richlin, Danielle // AAOHN Journal;May2004, Vol. 52 Issue 5, p186
Presents information on a medical case of bradycardia induced by hypercalemia. Medical history of the patient; Characteristics of bradycardia; Treatment of bradycardia.
- Arrhythmia. // New Harvard Guide to Women's Health;2004, p57
Presents information on arrhythmia. Description of arrhythmia; Reason for the occurrence of arrhythmia; Types of arrhythmias; Symptoms; Evaluation and treatment.
- Coping with rapid, irregular heartbeat. Lipman, Marvin M. // Consumer Reports on Health;Mar2003, Vol. 15 Issue 3, p11
Focuses on the causes of and strategies for coping with heart-rhythm disorders. Indications of atrial enlargement, overactive thyroid and lung disease among patients with the disorder; Range of treatment choices.
- Fabry disease and treatment with agalsidase alpha: unsuspected cardiac arrhythmia in two heterozygous women. Mougenot, Philippe; Lidove, Olivier; Caillaud, Catherine; Arnaud, Philippe; Papo, Thomas // European Journal of Clinical Pharmacology;Jun2008, Vol. 64 Issue 6, p635
Two women treated with agalsidase alpha for Fabry disease developed severe heart dysfunctions a few months after the beginning of enzyme replacement therapy (ERT). An adverse effect caused by the treatment was suspected; therefore we informed the French pharmacovigilance authorities about these...
- Specific Therapy Based on the Genotype and Cellular Mechanism in Inherited Cardiac Arrhythmias. Long QT Syndrome and Brugada Syndrome. Shimizu, Wataru; Aiba, Takeshi; Antzelevitch, Charles // Current Pharmaceutical Design;May2005, Vol. 11 Issue 12, p1561
Seven forms of congenital long QT syndrome (LQTS) caused by mutations in ion channel genes have been identified. Genotype-phenotype correlation in clinical and experimental studies involving arterially-perfused canine left ventricular wedges suggest that ï¿½-blockers are protective in LQT1,...
- Patent foramen ovale closure. Pro and cons. Onorato, Eustaquio; Casilli, Francesco; Berti, Marco; Anzola, Gian Paolo // Neurological Sciences;May2008 Supplement 1, Vol. 29, p28
Because patent foramen ovale (PFO) represents a lesion which may be repaired a number of expert clinicians believe that mechanical closure should be the primary treatment modality for patients with PFO after cryptogenic stroke; interest has grown on percutaneous devices and in the last years...
- Predictive value of history taking and physical examination in diagnosing arrhythmias in general practice. Emmy Hoefman; Kimberly R Boer; Henk CPM van Weert; Johannes B Reitsma; Rudolph W Koster; Patrick JE Bindels // Family Practice;Dec2007, Vol. 24 Issue 6, p636
Background. Palpitations and light-headedness are common symptoms that may be indicative of cardiac arrhythmias. Effective triage by the GP might prevent delayed treatment or inappropriate referrals. The aim of this study was to determine the capability of GPs to assess the presence of cardiac...